Gruppo di Ricerca in Psichiatria di Consultazione e Medicina Psicosomatica.

L'obiettivo del gruppo di ricerca in Psichiatria di Consultazione e Medicina Psicosomatica è quello di studiare (i) le manifestazioni psichiatriche che insorgono in pazienti affetti da patologie internistiche (per es. patologie oncologiche, cardiache, metaboliche, neurologiche, dermatologiche), (ii) l’impatto delle patologie internistiche sul decorso e la fisiopatologia delle patologie psichiatriche, (iii) l’impatto delle patologie psichiatriche sul decorso e la fisiopatologia delle patologie internistiche, e (iv) le componenti cliniche e biologiche che mediano il rapporto tra patologie internistiche e psichiatriche.

 

Particolare attenzione viene data allo studio dei tratti di personalità, degli stili di coping, dei rapporti longitudinali tra le varie condizioni studiate, dei predittori di outcome e di risposta clinica, e dei biomarcatori di ambito molecolare e neurofisiopatologico.

 

Di seguito un elenco delle pubblicazioni di tale gruppo di ricerca:

 

PASQUINI M, BERARDELLI, BIONDI M, FABBRINI G. LE PATOLOGIE DI CONFINE TRA NEUROLOGIA E PSICHIATRIA. RIVISTA DI PSICHIATRIA 2022; 57: 106-114. IF 1,9.

 

CANEVELLI M, BERSANI FS, SCIANCALEPORE F, SALZILLO M, CESARI M, TARSITANI L, PASQUINI M, FERRACUTI S, BIONDI M, BRUNO G. FRAILTY IN CAREGIVERS AND ITS RELATIONSHIP WITH PSYCHOLOGICAL STRESS AND RESILIENCE: A CROSS-SECTIONALSTUDY BASED ON THE DEFICIT ACCUMULATION MODEL. J FRAILTY AGING .2022;11(1):59-66. DOI: 10.14283/JFA.2021.29. IF 3.9.

 

COSTANZO M, BELVISI D, BERARDELLI I, MARAONE A, BAIONE V, FERRAZZANO G, CUTRONA G, LEODORI G, PASQUINI M, CONTE A, FABBRINI G, DEFAZIO G AND BERARDELLI A. EFFECT OF BOTULINUM TOXIN ON NON-MOTOR SYMPTOMS IN CERVICAL DYSTONIA. TOXINS 2021, 13, 647, 2-12. IF 4,546.

 

BERARDELLI I, MARAONE A, BELVISI D, PASQUINI M, GIUSTINI S, MIRAGLIA E, IACOVINO C, POMPILI M, FRASCARELLI M, FABBRINI G. THE IMPORTNACE OF SUICICE RISK ASSESSMENT IN PATIENTS AFFECTED BY NEUROFIBROMATOSIS. INT J PSYCHIATRY CLIN PRACT. 2021 JUL 16:1-5. DOI 10.1080/13651501.2021.1921217. ONLINE AHEAD OF PRINT. IF 2,1

 

BELVISI D, BERARDELLI I, MARAONE A , D’ANTONIO F , BAIONE V ,  TOSCANO  A,FERRAZZANO  G, PASQUINI M, CONTE A, FABBRINI G, DEFAZIO G, BERARDELLI A. MOTOR AND NON-MOTOR SUBTYPES OFCERVICAL DYSTONIA. PARKINSONISM AND RELATED DISORDERS, 2021, 88. 108-113. IF 4,98.

 

COSTANZO M., BELVISI D., BERARDELLI I., MARAONE A., D’ANTONIO F., BAIONE V, TOSCANO A., FERRAZZANO G., PASQUINI M., CONTE A., FABBRINI G., DEFAZIO G., BERARDELLI A. MOTOR AND NON-MOTOR SUBTYPES OF CERVICAL DYSTONIA. PARKINSONISM AND RELATED DISORDERS 88 (2021) 108-113. IF 4,891.

 

BERSANI FS, CANEVELLI M, CESARI M, MAGGIONI E, PASQUINI M, WOLKOWITZ OM, FERRACUTI S, BIONDI M, BRUNO G. FRAILTY INDEX AS A CLINICAL MEASURE OF BIOLOGICAL AGE IN PSYCHIATRY. J AFFECT DISORD. 2020;268:183-187.

 

BERARDELLI I, BELVISI D, PASQUINI M, FABBRINI A, PETRINI F, FABBRINI G. TREATMENT OF PSYCHIATRIC DISTURBANCES IN HYPOKINETIC MOVEMENT DISORDERS. EXPERT REV NEUROTHER. 2019 JUN 26.  IF 3.743

 

SEVERINO P, MARIANI MV, MARAONE A, PIRO A, CECCACCI A, TARSITANI L, MAESTRINI V, MANCONE M, LAVALLE C, PASQUINI M, FEDELE F. TRIGGERS FOR A TRIAL FIBRILLATION: THE ROLE OF ANXIETY. CARDIOLOGY RESEARCH AND PRACTICE 2019 MAR IN PRESS. IF 1,63.

 

BERARDELLI I, PASQUINI M, CONTE A, BOLOGNA M, BERARDELLI A, FABBRINI G. TREATMENT OF PSYCHIATRIC DISTURBANCES IN COMMON HYPERKINETIC MOVEMENT DISORDERS. EXPERT REV NEUROTHER. 2019 19(1), pp. 55-65. IF 3,743

 

BERSANI FS, GHEZZI F, MARAONE A, VICINANZA R, CAVAGGIONI G, BIONDI M, PASQUINI M. THE RELATIONSHIP BETWEEN VITAMIN D AND DEPRESSIVE DISORDERS. RIV PSICHIATR. 2019; 54:229-234.

 

BIONDI M, BERSANI FS, PASQUINI M. THE ROLE OF INTEGRATED INTERVENTIONS IN PSYCHOSOMATIC DISEASES. IN GRASSI ET AL (EDS.), PERSON CENTERED APPROACH TO RECOVERY IN MEDICINE INTEGRATING PSYCHIATRY AND PRIMARY CARE, SPRINGER INTERNATIONAL PUBLISHING 2019

 

BELVISI D, BERARDELLI I, SUPPA A, FABBRINI A, PASQUINI M, POMPILI M, FABBRINI G. NEUROPSYCHIATRIC DISTURBANCES IN ATYPICAL PARKINSONIAN DISORDERS. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018 14, 2643-2656. IF 2,570.

 

SCIARRA A, GENTILUCCI A, SALCICCIA S, VON HELAND M, RICCIUTI GP, MARZIO V, PIERELLA F, MUSIO D, TOMBOLINI V, FRANTELLIZZI V, PASQUINI M, MARAONE A, GUANDALINI A, MAGGI M. PSYCHOLOGICAL AND FUNCTIONAL EFFECT OF DIFFERENT PRIMARY TREATMENTS FOR PROSTATE CANCER: A COMPARATIVE PROSPECTIVE ANALYSIS. UROL ONCOL. 2018 APR 26. PII: S1078-1439(18)30121-2. DOI: 10.1016/J.UROL ONCOL .2018.03.022. IF 3,498.

 

BERARDELLI I., BLOISE MC., BOLOGNA M., CONTE A., POMPILI M., LAMIS DA., PASQUINI M. FABBRINI G. COGNITIVE BEHAVIORAL GROUP THERAPY VERSUS PSYCHOEDUCATIONAL INTERVENTION IN PARKINSON’S DISEASE. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018:14, 399-405. IF 2,228.

 

CONTE A, BERARDELLI I, FERRAZZANO G, PASQUINI M, BERARDELLI A, FABBRINI G. NON-MOTOR SYMPTOMS IN PATIENTS WITH ADULT-ONSET FOCAL DYSTONIA: SENSORY AND PSYCHIATRIC DISTURBANCES. PARKINSONISM AND RELATED DISORDERS, 2016 JAN;22 S111-4. IF 4,891

 

BERARDELLI I, FERRAZZANO G, PASQUINI M, BIONDI M, BERARDELLI A, FABBRINI G. CLINICAL COURSE OF PSYCHIATRIC DISORDERS IN PATIENTS WITH CERVICAL DYSTONIA. PSYCHIATRY RESEARCH, 2015 SEP 30;229(1-2):583-585. IF 2,46.

 

BERARDELLI I, PASQUINI M, ROSELLI V, BIONDI M, BERARDELLI A, FABBRINI G. COGNITIVE BEHAVIORAL THERAPY IN MOVEMENT DISORDERS: A REVIEW. MOVEMENT DISORDERS - CLINICAL PRACTICE. 2015, VOL. 2 ISSUE 2. IF 0,76.

 

BIONDI M, PASQUINI M. DIMENSIONAL PSYCHOPHARMACOLOGY IN SOMATISING   PATIENTS. ADVANCES IN PSYCHOSOMATIC MEDICINE, 2015;34:24-35 IF 2,44.

 

BERARDELLI I, PASQUINI M, BLOISE M, TARSITANI L, BIONDI M, BERARDELLI A, FABBRINI G. CBT GROUP INTERVENTION FOR DEPRESSION, ANXIETY, AND MOTOR SYMPTOMS IN PARKINSON'S DISEASE: PRELIMINARY FINDINGS. INTERNATIONAL JOURNAL OF COGNITIVE THERAPY, 2015;8,1,11-20. IF 1,821.

 

BLOISE MC, BERARDELLI I, ROSELLI V, PASQUINI M, STIRPE P, COLOSIMO C, BERARDELLI A, FABBRINI G. PSYCHIATRIC DISTURBANCES IN PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY: A CASE-CONTROL STUDY. PARKINSONISM AND RELATED DISORDERS, 2014 SEP;20(9):965-968.IF 3,926.

 

PASQUINI M, CELLETTI C, BERARDELLI I, ROSELLI V, MASTROENI S, CASTORI M, BIONDI M, CAMEROTA F. UNEXPECTED ASSOCIATION BETWEEN JOINT HYPERMOBILITY SYNDROME/EHLERS-DANLOS SYNDROME HYPERMOBILITY TYPE AND OBSESSIVE-COMPULSIVE PERSONALITY DISORDER. RHEUMATOLOGY INTERNATIONAL, 2014, MAY;34(5):631-636. IF 2,686.

 

FABBRINI G, BERARDELLI I, FALLA M, MORETTI G, PASQUINI M, ALTIERI M, DE FAZIO G, BIONDI M, BERARDELLI A. PSYCHIATRIC DISORDERS IN PATIENTS WITH ESSENTIAL TREMOR. PARKINSONISM AND RELATED DISORDERS, 2012 SEP;18(8):971-973.IF 3,920.

 

PASQUINI M, BERARDELLI I, CALABRÒ F, ROSELLI V, HEFNER S, BIONDI M. IS AMISULPRIDE SAFE WHEN PRESCRIBED TO BREAST AND PROSTATE CANCER PATIENTS? MEDICAL HYPOTHESES, 2013 SEP 182013 DEC;81(6):1146-1150. IF 1,375

 

FABBRINI G, BERARDELLI I, FALLA M, MORETTI G, PASQUINI M, ALTIERI M, DEFAZIO G, BIONDI M, BERARDELLI A. PSYCHIATRIC DISORDERS IN PATIENTS WITH ESSENTIAL TREMOR. PARKINSONISM AND RELATED DISORDERS, 2012 SEP;18(8):971-973. IF 3,926.

 

PASQUINI M, BERARDELLI I, CABRA A, MARAONE A, MATTEUCCI G, BIONDI M. CORE DEPRESSIVE SYMPTOMS IN DEPRESSED CANCER OUTPATIENTS. CLINICAL PRACTICE EPIDEMIOLOGY IN MENTAL HEALTH, 2011;7:178-181. IF 0.

 

CASCIATO S, DI BONAVENTURA C, LAPENTA L, FATTOUCH J, FERRAZZANO G, FANELLA M, DI FABIO F, PASQUINI M, AMENDOLEA MA, MANFREDI M, PRENCIPE M, GIALLONARDO AT. RECURRENT PARTIAL SEIZURES WITH ICTAL YAWNING AS ATYPICAL PRESENTATION OF HASHIMOTO'S ENCEPHALOPATHY (STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS). EPILEPSY & BEHAVIOR, 2011 DEC;22(4):799-803. IF 2,508.

 

DELLE CHIAIE R, IANNUCCI G, PAROLI M, SALVIATI M, CAREDDA M, PASQUINI M, BIONDI M. SYMPTOMATIC SUBSYNDROMAL DEPRESSION IN HOSPITALIZED HYPERTENSIVE PATIENTS. JOURNAL OF AFFECTIVE DISORDERS, 2011 DEC;135(1-3):168-176. IF 4,839.

 

FABBRINI G, BERARDELLI I, MORETTI G, PASQUINI M, COLOSIMO C, BERARDELLI A. PSYCHIATRIC DISORDERS IN ADULT ONSET FOCAL DYSTONIA. MOVEMENT DISORDERS, 2011 JULY, 1572. IF 8,679.

 

FABBRINI G, BERARDELLI I, MORETTI G, PASQUINI M, COLOSIMO C, BERARDELLI A. NONMOTOR SYMPTOMS IN ADULT-ONSET FOCAL DYSTONIA: PSYCHIATRIC ABNORMALITIES. MOVEMENT DISORDERS, 2011 AUG,1764-65. IF 8,679

 

SUPPA A, BELVISI D, BOLOGNA M, MARSILI L, BERARDELLI I, MORETTI G, PASQUINI M, FABBRINI G, BERARDELLI A. ABNORMAL CORTICAL AND BRAIN STEM PLASTICITY IN GILLES DE LA TOURETTE SYNDROME. MOVEMENT DISORDERS,2011 AUG 1;26(9):1703-1710. IF 8,679.

 

FABBRINI G, BERARDELLI I, MORETTI G, PASQUINI M, COLOSIMO C, BERARDELLI A. PSYCHIATRIC DISORDERS IN ADULT ONSET FOCAL DYSTONIA: A CASE CONTROL STUDY. MOVEMENT DISORDERS, 2010 MAR 15;25(4):459-465.IF 8,679.

 

PASQUINI M, BERARDELLI I, CABRA A. USEFULNESS OF MIRTAZAPINE IN CANCER PATIENTS. CLINICAL MANAGEMENT ISSUES, 2010; 4(3): 93-97. IF 1,0.

 

PASQUINI M, BERARDELLI I. ANXIETY LEVELS AND RELATED PHARMACOLOGICAL DRUG TREATMENT: A MEMORANDUM FOR THE THIRD MILLENNIUM. ANN IST SUPER SANITÀ 2009, VOL. 45, NO. 2: 193-204.IF 1,663.

 

PASQUINI M, SPECA A, MASTROENI S, DELLE CHIAIE R, STERNBERG CN, BIONDI M.  DIFFERENCES IN DEPRESSIVE THOUGHTS BETWEEN MAJOR DEPRESSIVE DISORDER, IFN-Α INDUCED DEPRESSION AND DEPRESSIVE DISORDERS AMON CANCER PATIENTS. JOURNAL OF PSYCHOSOMATIC RESEARCH, 2008 65, 153-156.  IF 3,268.

 

PASQUINI M, SPECA A, BIONDI M. QUIETAPINE FOR TAMOXIFEN-INDUCED INSOMNIA IN WOMEN WITH BREAST CANCER. PSYCHOSOMATICS, 2009, 50,2, 159-161. IF 1,66.

 

FABBRINI G, PASQUINI M, AURILIA C, BONIFATI V, BERARDELLI I, BERARDELLI A. A LARGE ITALIAN FAMILY WITH GILLES DE LA TOURETTE SYNDROME: A CLINICAL STUDY. MOVEMENT DISORDERS, 2007, 22, 15, 2229–2234. IF 8,679.

 

PASQUINI M, BIONDI M. DEPRESSION IN CANCER PATIENTS: A CRITICAL REVIEW. CLINICAL PRACTICE AND EPIDEMIOLOGY IN MENTAL HEALTH, 2007 8, 3:2. IF 0.

 

PASQUINI M, BIONDI M, COSTANTINI A, CAIROLI F, FERRARESE G, PICARDI A, AND STERNBERG C. DETECTION AND TREATMENT OF DEPRESSIVE AND ANXIETY DISORDERS AMONG CANCER PATIENTS: FEASIBILITY AND PRELIMINARY FINDINGS FROM A LIAISON SERVICE IN AN ONCOLOGY DIVISION’.  DEPRESSION AND ANXIETY, 2006; 23(7):441-448. IF 4,7.

 

PASQUINI M, TRINCIA V, GARAVINI A, BIONDI M: MIRTAZAPINE FOR HYPERHIDROSIS. PSYCHOSOMATICS, 2003 Sep-Oct;44(5):442-443. IF 1,66.

 

PASQUINI M, PUZELLA A, TRINCIA V, ALMERIGHI C, ARTINI M, LEVRERO M, BIONDI M. PSICOPATOLOGIA E DEPRESSIONE INDOTTA DA TERAPIA CON IFN-ALFA IN PAZIENTI AFFETTI DA EPATOPATIA CRONICA DA VIRUS C. RIVISTA DI PSICHIATRIA 2003, 38 (3), 138-141. IF 1,184.

 

MAES M, BONACCORSO S, MARINO V, PUZELLA A, PASQUINI M, BIONDI M, ARTINI M, ALMERIGHI C, MELTZER H. INCREASED DEPRESSIVE RATINGS IN HEPATITIS-C PATIENTS RECEIVING INTERFERON-ALPHA (IFNα) BASED IMMUNOTHERAPY ARE RELATED TO IFNα-INDUCED CHANGES IN THE SEROTONERGIC SYSTEM.  JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 2002; 2, 475-80. IF 2,7.

 

BONACCORSO S, PUZELLA A, MARINO V, PASQUINI M, BIONDI M, ARTINI M, ALMERIGHI C, LEVRERO M, EGYED B, BOSMANS E, MELTZER H., MAES M. IMMUNOTHERAPY WITH INTERFERON-ALPHA IN PATIENTS AFFECTED BY CHRONIC HEPATITIS C INDUCES AN INTERCORRELATED STIMULATION OF THE CYTOKINE NETWORK AND AN INCREASE IN DEPRESSIVE AND ANXIETY SYMPTOMS. PSYCHIATRY RESEARCH; 105,2001,45-55. IF 2,46

 

MAES M, BONACCORSO S, MARINO V, PUZELLA A, PASQUINI M, BIONDI M, ARTINI M, ALMERIGHI C, MELTZER H. TREATMENT WITH INTERFERON-ALPHA (IFNα) OF HEPATIS-C PATIENTS INDUCES LOWER SERUM DIPEPTIDYL PEPTIDASE IV ACTIVITY, WHICH IS RELATED TO IFNα-INDUCED DEPRESSIVE AND ANXIETY SYMPTOMS AND IMMUNE ACTIVATION. MOLECULAR PSYCHIATRY 200

Responsabile del Gruppo

Massimo Pasquini

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma